A carregar...
Co-prescribing naloxone does not increase liability risk
The opioid overdose epidemic claims the lives of tens of thousands of Americans every year. Opioid overdose is reversible by the administration of naloxone, a pure antagonist now available in formulations specifically designed and labeled for layperson use. Despite broad support for layperson access...
Na minha lista:
| Publicado no: | Subst Abus |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5567808/ https://ncbi.nlm.nih.gov/pubmed/27648764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08897077.2016.1238431 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|